The BioPharmaceutical manufacturing industry is experiencing an inflection point. Competition, price controls, globalization, biosimilars, and technology shifts have resulted in a new approach to building and operating manufacturing facilities. Amgen is on the leading edge of this change, building new ...
Year: 2014
Sanofi's Rare Disease subsidiary Genzyme is embarking on a process data analytics initiative to improve processes in manufacturing. Sanofi is also embarking on a core standardization initiative in Manufacturing Quality Operations, with the goal of streamlining the implementation process for ...
Year: 2014
Within the regulated industries, the OSIsoft PI System can be considered a GMP critical application. In the past, OSIsoft PI Systems were validated according to each site’s local procedures. This presentation will explain how J&J came to a common and ...
Year: 2014
What is RtReports Compliance Version and how is it used in the Pharmaceutical Industry? ...
Year: 2014
A pharmaceutical facility had lost a batch, a multi-million dollar loss, due to a DeltaV Embedded Historian failure. Review of the feasibility of redundant historians showed options were cost prohibitive. The user needed a robust architecture that implemented available OSIsoft ...
Year: 2014